The relationship between the wound contraction and levels of α-smooth muscle actin (α-SMA) has been revealed in different studies. We aimed to investigate the effects of mesenchymal stem cells (MSCs), mainly bone-marrow-derived stem cells (BSCs) and adipose-derived stem cells (ASCs), and find out the α-SMA, fibroblast growth factor (FGF), transforming growth factor beta, and vascular endothelial growth factor (VEGF) levels on an in vivo acute wound healing model after the application of MSCs.
Approach:
Four circular skin defects were formed on the dorsum of Fisher rats (n=20). The defects were applied phosphate-buffered saline (PBS), ASCs, BSCs, and patchy skin graft, respectively. The healing time and scar area were noted.
Results:
There was a statistical decrease in the healing time in ASC, BSC, and skin graft groups (p<0.05). However, the scar was smaller in the PBS group (p<0.05). The α-SMA levels were statistically lower in ASC, BSC, and graft groups (p<0.05). The FGF levels were statistically higher in ASC and BSC groups (p<0.05). The differentiation of the injected MSCs to endothelial cells and keratinocytes was observed.
Innovation and Conclusion:
MSCs decrease the healing time and contraction of the wound while increasing the epithelization rate by increasing angiogenesis.
Get full access to this article
View all access options for this article.
References
1.
WilliamsIR and KupperTS: Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci, 1996; 58: 1485.
2.
DesmouliereA and GabbianiG: Modulation of fibroblastic cytoskeletal features during pathological situations: the role of extracellular matrix and cytokines. Cell Motil Cytoskeleton, 1994; 29: 195.
3.
GabbianiG, RyanGB, and MajneG: Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia, 1971; 27: 549.
4.
DesmouliereA and GabbianiG: The role of myofibroblast in wound healing and fibrocontractive diseases. In: The Molecular and Cellular Biology of Wound Repair, 2nd edition, edited by ClarkRAF. New York, Plenum, 1996, pp. 321–323.
5.
DesmouliereA, ChaponnierC, and GabbianiG: Tissue repair, contraction, and the myofibroblast. Wound Repair Regen, 2005; 13: 7.
6.
GabbianiG: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol, 2003; 200: 500.
7.
HinzB and GabbianiG: Mechanisms of force generation and transmission by myofibroblasts. Curr Opin Biotechnol, 2003; 14: 538.
8.
AroraPD and McCullochCA: Dependence of collagen remodeling on alpha-smooth muscle actin expression by fibroblasts. J Cell Physiol, 1994; 159: 161.
HinzB, MastrangeloD, IselinCE, ChaponnierC, and GabbianiG: Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol, 2001; 159: 1009.
11.
AkasakaY, OnoI, TominagaA, et al.: Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of alpha-smooth muscle actin, leading to reduction of wound contraction. Wound Repair Regen, 2007; 15: 378.
12.
SpornMB and RobertsAB: A major advance in the use of growth factors to enhance wound healing. J Clin Invest, 1993; 92: 2565.
13.
GurtnerGC, CallaghanMJ, and LongakerMT: Progress and potential for regenerative medicine. Annu Rev Med, 2007; 58: 299.
14.
RafiiS and LydenD: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med, 2003; 9: 702.
15.
Planat-BenardV, SilvestreJS, CousinB, et al.: Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation, 2004; 109: 656.
16.
FuX and LiH: Mesenchymal stem cells (MSCs) and skin wound repair and regeneration: possibilities and questions. Cell Tissue Res, 2009; 335: 317.
17.
GoldbergMT, HanYP, YanC, ShawMC, and GarnerWL: TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol, 2007; 127: 2645.
18.
SpyrouGE and NaylorIL: The effect of basic fibroblast growth factor on scarring. Br J Plast Surg, 2002; 55: 275.
19.
OgawaR, MizunoH, WatanabeA, MigitaM, ShimadaT, and HyakusokuH: Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice. Biochem Biophys Res Commun, 2004; 313: 871.
20.
LuF, MizunoH, UysalCA, CaiX, OgawaR, and HyakusokuH: Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg, 2008; 121: 50.
21.
DarbyI, SkalliO, and GabbianiG: Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest, 1990; 63: 21.
22.
SasakiM, AbeR, FujitaY, AndoS, InokumaD, and ShimizuH: Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol, 2008; 180: 2581.
23.
WuY, WangJ, ScottPG, and TredgetEE: Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen, 2007; 15Suppl 1: S18.
24.
HansenSL, YoungDM, and BoudreauNJ: HoxD3 expression and collagen synthesis in diabetic fibroblasts. Wound Repair Regen, 2003; 11: 474.
25.
HanSK, YoonTH, LeeDG, LeeMA, and KimWK: Potential of human bone marrow stromal cells to accelerate wound healing in vitro. Ann Plast Surg, 2005; 55: 414.
26.
LammeEN, Van LeeuwenRT, BrandsmaK, Van MarleJ, and MiddelkoopE: Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation. J Pathol, 2000; 190: 595.
27.
DesmouliereA, GeinozA, GabbianiF, and GabbianiG: Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol, 1993; 122: 103.
MoreiraME and MarkovchickVJ: Wound management. Emerg Med Clin North Am, 2007; 25: 873.
30.
YoshikawaT, MitsunoH, NonakaI, et al.: Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg, 2008; 121: 860.
31.
StoffA, RiveraAA, Sanjib BanerjeeN, et al.: Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp Dermatol, 2009; 18: 362.
32.
KwonDS, GaoX, LiuYB, et al.: Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. Int Wound J, 2008; 5: 453.
33.
NambuM, IshiharaM, NakamuraS, et al.: Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissue-derived stromal cells within an atelocollagen matrix. Wound Repair Regen, 2007; 15: 505.
34.
TomiyamaK, MuraseN, StolzDB, et al.: Characterization of transplanted green fluorescent protein+ bone marrow cells into adipose tissue. Stem Cells, 2008; 26: 330.
35.
NiemeyerP, KornackerM, MehlhornA, et al.: Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng, 2007; 13: 111.
36.
SeifterE, RetturaG, PadawerJ, StratfordF, KambososD, and LevensonSM: Impaired wound healing in streptozotocin diabetes. Prevention by supplemental vitamin A. Ann Surg, 1981; 194: 42.
37.
SlavinJ: The role of cytokines in wound healing. J Pathol, 1996; 178: 5.
38.
GreenhalghDG: The role of growth factors in wound healing. J Trauma, 1996; 41: 159.
39.
McFarlinK, GaoX, LiuYB, et al.: Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen, 2006; 14: 471.
